In addition to modulating tumor-intrinsic factors, IGF2BP3 has been implicated in the immunomodulation of the tumor microenvironment, from the upregulation of immune checkpoint inhibitors to the polarization of tumor-associated macrophages (TAMs) towards an immunosuppressive phenotype [25,48,49]. This evidence concerns the gene IGF2BP3 and neoplasm.